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Several local anaesthetics and tranquillizers have
been shown to interact with the cellular membranes
(Seeman et al., 1972; Feinstein et al., 1975;
Papahadjopoulos et al., 1975). Among these, the
commonly used phenothiazine tranquillizer chlor-
promazine potentiated the hyperthermic response
of a mouse fibrosarcoma (George & Singh, 1982).
Since plasma membrane is also involved in the
hyperthermic killing of cells (Har-Kedar & Bleehen,
1976), we have investigated the combined effect of
heat and three other phenothiazine drugs viz.
promethazine (PMZ); prochlorperazine (PCP) and
trimeprazine (TMZ) on a mouse fibrosarcoma. The
present study assumes considerable importance in
view of their reported antitumour, chemo- and
radio-sensitizing activities (Kanzawa et al., 1970;
George & Singh, 1984).
All drugs were pharmaceutical grade (May &
Baker Ltd., India) and were used without any
further purification. Their structural formulae and
therapeutic uses are described elsewhere (George &
Singh, 1984).
Aseriallytransplantablefibrosarcoma (Waravdekar
& Ranadive, 1957) was used as the test system.
Tumours were grown subcutaneously on the chest
wall of 8-week-old female Swiss mice weighing 17-
25 g. When the tumours reached a mean diameter
of 8 + 1 mm, the mice were randomly distributed
into 4 groups comprising control animals and those
receiving any of these drugs or heat or both. The
drugs were dissolved in sterile normal saline at a
concentration of 0.4-4mgml-1. Each drug at doses
of 2, 25 or 40mgkg-1 body wt. was given as a
single i.v. injection through the tail vein with a 27-
gauge needle in a volume of 0.09-0.25ml solution
to unanaesthetised tumour bearing animals 5-
10min before heating. The control animals received
an equal volume of normal saline. All heat treat-
ments were given for 1 h, excluding the time taken
by the tumour to attain the maximum temperature.
The method of heating the tumours and the
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measurements of the intratumour and rectal tem-
peratures were as described previously (George &
Singh, 1982). Briefly, tumours were locally heated
by immersing in a thermostatically controlled
(±+0.1C) waterbath (Gallenkamp, U.K.) fitted with
a stirrer. Within 5-10min the tumours attained a
temperature 0.5+0.2°C less than that of the water-
bath which was maintained throughout the
duration of the heating. It is known that the
temperature across a tumour may vary con-
siderably, but the intratumour temperature referred
to in our study is the central tumour temperature.
Tumour regrowth delay was used as the criterion
for assessing the response to various treatments.
After each treatment the diameter of tumours were
measured in 3 perpendicular directions and a
geometric mean was calculated. The effectiveness of
the treatments was assessed from the average time
taken by the tumour to reach a diameter of 11 mm
after each treatment.
At 2mgkg-1 body wt. all the drugs reduced the
body temperature by 2°C but did not influence the
tumour growth. At 25mgkg-1 they produced a
further drop in body temperature and also caused a
small but measurable growth delay. At a higher
dose of 40mgkg-1 however, they considerably
reduced the body temperature to 30.6°C and also
significantly inhibited tumour growth; their
effectiveness being TMZ>PCP=PMZ (growth
delays 2.3+0.5; 1.4+0.5 and 0.9+0.5 days
respectively). Antitumour activity of such
phenothiazines has been reported earlier (Kanzawa
et al., 1970; Hilf et al., 1971; Polliak & Levij, 1972)
but the drug doses used in all these studies to
obtain any sigrficant effect were too large to
permit their use as chemotherapeutic agents. In
addition, during local hyperthermic treatment of
tumours at 41-43°C when the body temperature
rose to 37.5°C, drug doses >2mgkg-1 proved
lethal. Drugs at this dose only were therefore used
in combination with heat.
It can be seen from Figure 1 that heat alone at
41°C or in combination with any one of these drugs
at 2mgkg-1 yielded only minimal growth delays.
In contrast, administration of any one of these
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drugs before heating the tumours to 42 or 43°C
caused substantial delays in tumour growth
compared to the tumours heated without these
drugs. Their relative effectiveness was found to be
TMZ>PMZ=PCP. A detailed study on TMZ
showed that it was ineffective at 0.1 mgkg- but
equally affected the tumour growth at 0.5, 1 or
2mgkg-1 indicating a saturation in the effect at
0.5mgkg-' dose (growth delay at 43°C was
9.1+0.6 days). It is significant to note that the
acceptable clinical dose of TMZ is of the order of
0.6-0.9mgkg-1 ('Vallergan', May & Baker Ltd.,
U.K., 1972).
Figure 1 also shows the variation of growth
delays at 41, 42 and 43°C and it indicates that
while, in tumours treated with heat alone, advantage
may be achieved by increasing the temperature up
to 43°C; in combination treatment with these drugs
particularly TMZ and PMZ, the major benefit is
realised at 420C itself and treating at 43°C would
lead only to a marginal further advantage. Con-
sidering the fact that these and other membrane
active drugs interact with cellular membranes and
modify their microenvironment (Seeman, 1972;
Feinstein et al., 1975; Papahadjopoulos et al.,
1975; Singer, 1977) as well as their response to
heating (Yatvin, 1977), it is very likely that they
would also shift the temperature profiles for hyper-
thermic killing as seen in the present study. Such
information may prove useful in planning treatment









Figure 1 Effect of phenothiazine drugs and
hyperthermia on mouse fibrosarcoma. Drugs given
intravenously 5-10min before heating. Error bars
show the standard error. Number of tumours per
group 7-10. (0) Heat alone (Tumour core, 1 h); (AL)
PMZ 2mgkg-1 +heat; (A) PCP 2mgkg1 +heat; (C])
TMZ2mgkg- I +heat.
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